Our immunohistochemical examination of CDH3 expression revealed a significant loss of its signal in cancerous tissues, while immunopositivity was seen in noncancerous areas adjacent to the tumor site and in specimens from tumor-free kidneys. Here, CDH3 is linked to neoplasm.